世界のコンパニオンアニマル用薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Companion Animal Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z03588 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、コンパニオンアニマル用薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コンパニオンアニマル用薬の種類別市場規模（抗生物質・抗菌剤、寄生虫駆除剤、その他）、用途別市場規模（犬、猫、馬、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コンパニオンアニマル用薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Zoetis、Bayer、Boehringer Ingelheim、Eli Lilly、Merck、Vetoquinol、Virbac、Dechra Pharmaceuticals、Ceva Sante Animale、Aratana Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗生物質・抗菌剤、寄生虫駆除剤、その他 ・用途別分析2016年-2026年：犬、猫、馬、その他 ・コンパニオンアニマル用薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コンパニオンアニマル用薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コンパニオンアニマル用薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コンパニオンアニマル用薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コンパニオンアニマル用薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Companion Animal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Companion Animal Drugs size is estimated to be USD 30670 million in 2025 from USD 27560 million in 2019, with a change XX% between 2019 and 2020. The global Companion Animal Drugs market size is expected to grow at a CAGR of 2.7% for the next five years.

Market segmentation
Companion Animal Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Antibiotics and Antimicrobials
Parasiticides
Others

Market segment by Application, can be divided into
Dogs
Cats
Horses
Others

Market segment by players, this report covers
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Companion Animal Drugs
1.2 Classification of Companion Animal Drugs by Type
1.2.1 Overview: Global Companion Animal Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Companion Animal Drugs Revenue Market Share by Type in 2020
1.2.3 Antibiotics and Antimicrobials
1.2.4 Parasiticides
1.2.5 Others
1.3 Global Companion Animal Drugs Market by Application
1.3.1 Overview: Global Companion Animal Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Others
1.4 Global Companion Animal Drugs Market Size & Forecast
1.5 Global Companion Animal Drugs Market Size and Forecast by Region
1.5.1 Global Companion Animal Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Companion Animal Drugs Market Size by Region, (2016-2021)
1.5.3 North America Companion Animal Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Companion Animal Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Companion Animal Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Companion Animal Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Companion Animal Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Animal Drugs Market Drivers
1.6.2 Companion Animal Drugs Market Restraints
1.6.3 Companion Animal Drugs Trends Analysis
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Companion Animal Drugs Product and Solutions
2.1.4 Zoetis Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Companion Animal Drugs Product and Solutions
2.2.4 Bayer Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bayer Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Companion Animal Drugs Product and Solutions
2.3.4 Boehringer Ingelheim Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Companion Animal Drugs Product and Solutions
2.4.4 Eli Lilly Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Companion Animal Drugs Product and Solutions
2.5.4 Merck Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck Recent Developments and Future Plans
2.6 Vetoquinol
2.6.1 Vetoquinol Details
2.6.2 Vetoquinol Major Business
2.6.3 Vetoquinol Companion Animal Drugs Product and Solutions
2.6.4 Vetoquinol Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Vetoquinol Recent Developments and Future Plans
2.7 Virbac
2.7.1 Virbac Details
2.7.2 Virbac Major Business
2.7.3 Virbac Companion Animal Drugs Product and Solutions
2.7.4 Virbac Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Virbac Recent Developments and Future Plans
2.8 Dechra Pharmaceuticals
2.8.1 Dechra Pharmaceuticals Details
2.8.2 Dechra Pharmaceuticals Major Business
2.8.3 Dechra Pharmaceuticals Companion Animal Drugs Product and Solutions
2.8.4 Dechra Pharmaceuticals Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Dechra Pharmaceuticals Recent Developments and Future Plans
2.9 Ceva Sante Animale
2.9.1 Ceva Sante Animale Details
2.9.2 Ceva Sante Animale Major Business
2.9.3 Ceva Sante Animale Companion Animal Drugs Product and Solutions
2.9.4 Ceva Sante Animale Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Ceva Sante Animale Recent Developments and Future Plans
2.10 Aratana Therapeutics
2.10.1 Aratana Therapeutics Details
2.10.2 Aratana Therapeutics Major Business
2.10.3 Aratana Therapeutics Companion Animal Drugs Product and Solutions
2.10.4 Aratana Therapeutics Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Aratana Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Animal Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Animal Drugs Players Market Share
3.2.2 Top 10 Companion Animal Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Companion Animal Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Animal Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Companion Animal Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Companion Animal Drugs Revenue Market Share by Application (2016-2021)
5.2 Companion Animal Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Companion Animal Drugs Revenue by Type (2016-2026)
6.2 North America Companion Animal Drugs Revenue by Application (2016-2026)
6.3 North America Companion Animal Drugs Market Size by Country
6.3.1 North America Companion Animal Drugs Revenue by Country (2016-2026)
6.3.2 United States Companion Animal Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Companion Animal Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Companion Animal Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Animal Drugs Revenue by Type (2016-2026)
7.2 Europe Companion Animal Drugs Revenue by Application (2016-2026)
7.3 Europe Companion Animal Drugs Market Size by Country
7.3.1 Europe Companion Animal Drugs Revenue by Country (2016-2026)
7.3.2 Germany Companion Animal Drugs Market Size and Forecast (2016-2026)
7.3.3 France Companion Animal Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Companion Animal Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Companion Animal Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Companion Animal Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Animal Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Companion Animal Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region
8.3.1 Asia-Pacific Companion Animal Drugs Revenue by Region (2016-2026)
8.3.2 China Companion Animal Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Companion Animal Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Companion Animal Drugs Market Size and Forecast (2016-2026)
8.3.5 India Companion Animal Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Companion Animal Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Companion Animal Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Companion Animal Drugs Revenue by Type (2016-2026)
9.2 South America Companion Animal Drugs Revenue by Application (2016-2026)
9.3 South America Companion Animal Drugs Market Size by Country
9.3.1 South America Companion Animal Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Companion Animal Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Companion Animal Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Animal Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Companion Animal Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country
10.3.1 Middle East & Africa Companion Animal Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Companion Animal Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Companion Animal Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Companion Animal Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Companion Animal Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Companion Animal Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Companion Animal Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Companion Animal Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Companion Animal Drugs Revenue Market Share by Region (2021-2026)
Table 6. Zoetis Corporate Information, Head Office, and Major Competitors
Table 7. Zoetis Major Business
Table 8. Zoetis Companion Animal Drugs Product and Solutions
Table 9. Zoetis Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bayer Corporate Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Companion Animal Drugs Product and Solutions
Table 13. Bayer Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim Major Business
Table 16. Boehringer Ingelheim Companion Animal Drugs Product and Solutions
Table 17. Boehringer Ingelheim Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Companion Animal Drugs Product and Solutions
Table 21. Eli Lilly Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck Corporate Information, Head Office, and Major Competitors
Table 23. Merck Major Business
Table 24. Merck Companion Animal Drugs Product and Solutions
Table 25. Merck Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 27. Vetoquinol Major Business
Table 28. Vetoquinol Companion Animal Drugs Product and Solutions
Table 29. Vetoquinol Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Virbac Corporate Information, Head Office, and Major Competitors
Table 31. Virbac Major Business
Table 32. Virbac Companion Animal Drugs Product and Solutions
Table 33. Virbac Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Dechra Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Dechra Pharmaceuticals Major Business
Table 36. Dechra Pharmaceuticals Companion Animal Drugs Product and Solutions
Table 37. Dechra Pharmaceuticals Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Ceva Sante Animale Corporate Information, Head Office, and Major Competitors
Table 39. Ceva Sante Animale Major Business
Table 40. Ceva Sante Animale Companion Animal Drugs Product and Solutions
Table 41. Ceva Sante Animale Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Aratana Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Aratana Therapeutics Major Business
Table 44. Aratana Therapeutics Companion Animal Drugs Product and Solutions
Table 45. Aratana Therapeutics Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Companion Animal Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Companion Animal Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Companion Animal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Companion Animal Drugs Players Head Office, Products and Services Provided
Table 50. Companion Animal Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Companion Animal Drugs New Entrants and Expansion Plans
Table 52. Global Companion Animal Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Companion Animal Drugs Revenue Share by Type (2016-2021)
Table 54. Global Companion Animal Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Companion Animal Drugs Revenue by Application (2016-2021)
Table 56. Global Companion Animal Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Companion Animal Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Companion Animal Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Companion Animal Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Companion Animal Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Companion Animal Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Companion Animal Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Companion Animal Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Companion Animal Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Companion Animal Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Companion Animal Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Companion Animal Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Companion Animal Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Companion Animal Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Companion Animal Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Companion Animal Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Companion Animal Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Companion Animal Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Companion Animal Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Companion Animal Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Companion Animal Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Companion Animal Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Companion Animal Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Companion Animal Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Companion Animal Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Companion Animal Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Companion Animal Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Companion Animal Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Companion Animal Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Companion Animal Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Companion Animal Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Companion Animal Drugs Picture
Figure 2. Global Companion Animal Drugs Revenue Market Share by Type in 2020
Figure 3. Antibiotics and Antimicrobials
Figure 4. Parasiticides
Figure 5. Others
Figure 6. Companion Animal Drugs Revenue Market Share by Application in 2020
Figure 7. Dogs Picture
Figure 8. Cats Picture
Figure 9. Horses Picture
Figure 10. Others Picture
Figure 11. Global Companion Animal Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Companion Animal Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Companion Animal Drugs Revenue Market Share by Region (2016-2026)
Figure 14. Global Companion Animal Drugs Revenue Market Share by Region in 2020
Figure 15. North America Companion Animal Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Companion Animal Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Companion Animal Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Companion Animal Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Companion Animal Drugs Market Drivers
Figure 20. Companion Animal Drugs Market Restraints
Figure 21. Companion Animal Drugs Market Trends
Figure 22. Zoetis Recent Developments and Future Plans
Figure 23. Bayer Recent Developments and Future Plans
Figure 24. Boehringer Ingelheim Recent Developments and Future Plans
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Vetoquinol Recent Developments and Future Plans
Figure 28. Virbac Recent Developments and Future Plans
Figure 29. Dechra Pharmaceuticals Recent Developments and Future Plans
Figure 30. Ceva Sante Animale Recent Developments and Future Plans
Figure 31. Aratana Therapeutics Recent Developments and Future Plans
Figure 33. Global Companion Animal Drugs Revenue Share by Players in 2020
Figure 34. Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Companion Animal Drugs Revenue Market Share in 2020
Figure 36. Global Top 10 Players Companion Animal Drugs Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Companion Animal Drugs Revenue Share by Type in 2020
Figure 39. Global Companion Animal Drugs Market Share Forecast by Type (2021-2026)
Figure 40. Global Companion Animal Drugs Revenue Share by Application in 2020
Figure 41. Global Companion Animal Drugs Market Share Forecast by Application (2021-2026)
Figure 42. North America Companion Animal Drugs Sales Market Share by Type (2016-2026)
Figure 43. North America Companion Animal Drugs Sales Market Share by Application (2016-2026)
Figure 44. North America Companion Animal Drugs Revenue Market Share by Country (2016-2026)
Figure 45. United States Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Companion Animal Drugs Sales Market Share by Type (2016-2026)
Figure 49. Europe Companion Animal Drugs Sales Market Share by Application (2016-2026)
Figure 50. Europe Companion Animal Drugs Revenue Market Share by Country (2016-2026)
Figure 51. Germany Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Companion Animal Drugs Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Companion Animal Drugs Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Companion Animal Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Companion Animal Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America Companion Animal Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Companion Animal Drugs Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Companion Animal Drugs Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Companion Animal Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Companion Animal Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Companion Animal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---